Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 178 clinical trials
featured
CAHtalyst Study: A Research Study for Adults with Classic Congenital Adrenal Hyperplasia (CAH)

The CAHtalyst Study is a clinical research study evaluating an investigational medication for adults 18 years of age and older who have been diagnosed with classic congenital adrenal hyperplasia

classic congenital adrenal hyperplasia
congenital adrenal hyperplasia
  • 30 views
  • 23 Nov, 2020
  • 1 location
featured
PLUS 1 Study

PLUS 1 Study

  • 242 views
  • 08 Nov, 2020
  • 1 location
featured
An Open-Label Trial Of Oral Selegiline 5 Or 10 Mg And Tadalafil 2.5 Mg Co-Administration To Male Patients With Parkinson's Disease And Moderate Erectile Dysfunction.

An Open-Label Trial Of Oral Selegiline 5 Or 10 Mg And Tadalafil 2.5 Mg Co-Administration To Male Patients With Parkinson's Disease And Moderate Erectile Dysfunction.

  • 886 views
  • 08 Nov, 2020
  • 2 locations
featured
Enlarged Prostate or BPH

Enlarged Prostate or BPH

  • 396 views
  • 08 Nov, 2020
  • 1 location
featured
Men With Ejaculatory Problems

Men With Ejaculatory Problems

  • 200 views
  • 08 Nov, 2020
  • 1 location
MPA Versus Dydrogesterone for Management of Endometrial Hyperplasia Without Atypia

To compare the efficacy of Medroxyprogesterone Acetate with dydrogesterone in patients having endometrial hyperplasia (EH) without atypia.

  • 0 views
  • 25 Jan, 2021
  • 1 location
Global Safety and Efficacy Registration Study of Crinecerfont for Congenital Adrenal Hyperplasia

This is a Phase 3 study to evaluate the efficacy, safety, and tolerability of crinecerfont versus placebo administered for 24 weeks in approximately 165 adult subjects with classic CAH due to 21-hydroxylase deficiency. The study consists of a 6 month randomized, double blind, placebo-controlled period, followed by 1 year of …

21-ohd
deficiency
  • 94 views
  • 15 Apr, 2021
  • 24 locations
Congenital Adrenal Hyperplasia Once Daily Hydrocortisone Treatment

, metabolic syndrome, hormonal profile, bone status, quality of life, reproductive, sexual and psychological functions and treatment compliance in patients affected by congenital adrenal hyperplasia due to 21

dexamethasone
cortisone acetate
glucocorticoid therapy
deficiency
adrenal insufficiency
  • 56 views
  • 24 Jan, 2021
  • 1 location
Safety Tolerability Pharmacokinetics and Pharmacodynamics of NBI-74788 in Pediatric Subjects With Congenital Adrenal Hyperplasia

pediatric female and male subjects (14 to 17 years of age) with a documented medical diagnosis of classic 21-hydroxylase deficiency congenital adrenal hyperplasia (CAH).

21-ohd
deficiency
drugs of abuse
  • 18 views
  • 15 Apr, 2021
  • 6 locations
  • 0 views
  • 26 Mar, 2021
  • 2 locations